No Pharma Money
News & Reports
News July 22, 2019

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

What’s hotter in D.C. right now — drug prices or the heat index?

1. Trust No One

2. Oh, Canada ??

  • We want patients to buy prescriptions at reasonable prices, but we can’t rely on our northern neighbor forever. — (Reuters)

3. All a Blur

  • Tracking drug pricing proposals makes our heads spin on the weekly. Here’s a handy guide. — (STAT)

4. “My love for you is like drug list prices: inexplicable.”

  • Totally inexplicable. — (NPR)

5. Weekend Read

  • AbbVie’s abusive tactics to maintain its monopoly on its $20 billion blockbuster, Humira, thoroughly dissected. — (Fortune)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.